|
|
||||||||
Division of Thoracic Surgery, Massachusetts General Hospital, Boston, Massachusetts
Accepted for publication April 16, 2009.
* Address correspondence to Dr Lanuti, 55 Fruit St, Blake 1570, Boston, MA 01748 (Email: mlanuti{at}partners.org).
Presented at the Poster Session of the Forty-fifth Annual Meeting of The Society of Thoracic Surgeons, San Francisco, CA, Jan 26–28, 2009.
Background: Obstruction of the superior vena cava (SVC) by tumor or benign disease implies unreconstructable disease and poor outcome. We analyzed the operative results, graft patency, and survival in patients undergoing SVC resection and reconstruction for benign disease and pulmonary or mediastinal malignancy.
Methods: Patients undergoing SVC resection from 1997 to 2007 for surgical management of benign and invasive neoplasms were retrospectively reviewed.
Results: We identified 19 patients requiring SVC resection. Malignant disease was resected in 17: lung cancer in 9 and mediastinal malignancy in 8. Two patients (10%) with benign processes required reconstruction for chronic SVC syndrome. Ringed Gore-Tex conduit (W. L. Gore and Associates, Flagstaff, AZ) was used for 12 reconstructions (63%) of the SVC, and 7 patients underwent primary closure or autologous pericardial patch repair. Preoperative chemoradiotherapy was administered to 9 patients (53%). There was one perioperative death (5%). Major postoperative morbidities included atrial fibrillation in 5, stroke in 2, respiratory failure in 3, myocardial infarction in 1, and Horner syndrome in 1. Median survival for the entire cohort was 45.5 months (range, 0.2 to 147 months), with a mean follow-up of 45.8 months. Five-year survival probability was 30% for patients with resected lung cancer and 56% for patients with resected anterior mediastinal malignancies.
Conclusions: Resection and reconstruction may be safely performed in selected patients for benign and malignant obstruction or infiltration of the SVC. Survival and intermediate-term patency after tubular grafting of the SVC are acceptable.
Related Article
Ann. Thorac. Surg. 2009 88: 397-398.
This article has been cited by other articles:
![]() |
A. M. Ciccone, F. Venuta, A. D'Andrilli, C. Andreetti, M. Ibrahim, T. De Giacomo, D. Massullo, and E. A. Rendina Long-term patency of the stapled bovine pericardial conduit for replacement of the superior vena cava Eur J Cardiothorac Surg, December 1, 2011; 40(6): 1487 - 1491. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ohata, R. Nakahara, A. Ui, and H. Matsuguma Azygos flap as a novel method for superior vena cava reconstruction Interact CardioVasc Thorac Surg, November 1, 2010; 11(5): 519 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sekine, H. Suzuki, Y. Saitoh, H. Wada, and S. Yoshida Prosthetic Reconstruction of the Superior Vena Cava for Malignant Disease: Surgical Techniques and Outcomes Ann. Thorac. Surg., July 1, 2010; 90(1): 223 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Spaggiari Invited Commentary Ann. Thorac. Surg., August 1, 2009; 88(2): 397 - 398. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |